Clinical InvestigationVentricular Mechanics in Diverse DisordersAssessment of Longitudinal Myocardial Mechanics in Patients with Degenerative Mitral Valve Regurgitation Predicts Postoperative Worsening of Left Ventricular Systolic Function
Section snippets
Patient Selection
From January 2002 to December 2010, 744 patients underwent MVr for chronic severe degenerative MR; the data from these patients were analyzed retrospectively. Patients with occlusive coronary artery disease (n = 80 [10.8%]), connective tissue disorders (n = 3 [0.4%]), previous sternotomy (n = 44 [5.9%]), and additional valvulopathies (n = 37 [5%]), except for tricuspid regurgitation, were excluded. An additional 227 cases were excluded because they were not saved in Digital Imaging and
Results
Patients' baseline characteristics and values are presented in Table 1. Standard 2D transthoracic echocardiography was performed at baseline and 4 ± 3 days after MVr. MV reconstruction was successful in all patients. One patient (0.7%) required revisiting for residual moderate MR and underwent a successful repeat repair the following day. The underlying etiology of MR was fibroelastic deficiency (n = 54) and Barlow's disease (n = 76, including forme fruste Barlow's deformity). MV leaflet
Discussion
Our results show that LV GLS is an independent predictor of LV function reduction after MV reconstructive surgery, compared with 2D echocardiographic markers of chamber dimensions. Our principal findings were as follows: (1) Alterations in LVEF in patients with severe MR due to degenerative MV disease are primarily correlated with changes in long-axis LV mechanics, with minimal contribution from the circumferential or radial thickening components, and (2) hypercompensatory GLS in severe MR
Conclusions
In patients with chronic severe degenerative MR, disproportionately higher LV GLS signifies a maladaptive preload-related change that is associated with substantial loss of LVEF (>10%) immediately after MVr. Preoperative use of speckle-tracking echocardiography-derived longitudinal strain may be potentially useful for optimal timing of MVr for degenerative MR.
Acknowledgments
The authors thank Marissa Sansone (St George Medical School) and Janell Wright (Mount Holyoke College) for their help in preparing this report.
References (40)
- et al.
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines
J Thorac Cardiovasc Surg
(2012) - et al.
Latent left ventricular dysfunction in patients with mitral regurgitation: feasibility of measuring diminished contractile reserve from a simplified model of noninvasively derived left ventricular pressure-volume loops
Am Heart J
(1999) - et al.
Two-dimensional strain—a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo
J Am Soc Echocardiogr
(2005) - et al.
Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking
J Am Soc Echocardiogr
(2008) - et al.
Global longitudinal strain: a novel index of left ventricular systolic function
J Am Soc Echocardiogr
(2004) - et al.
Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation
J Am Soc Echocardiogr
(2012) - et al.
Echocardiographic predictors of left ventricular function and clinical outcomes after successful mitral valve repair: conventional two-dimensional versus speckle-tracking parameters
Ann Thorac Surg
(2011) - et al.
Assessment of myocardial deformation: predicting medium-term left ventricular dysfunction after surgery in patients with chronic mitral regurgitation
Rev Esp Cardiol
(2010) Cardiac valve surgery—the “French correction.”
J Thorac Cardiovasc Surg
(1983)- et al.
Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency
Semin Thorac Cardiovasc Surg
(2007)
Quantitation of mitral regurgitation
Semin Thorac Cardiovasc Surg
Determinants of pulmonary venous flow reversal in mitral regurgitation and its usefulness in determining the severity of regurgitation
Am J Cardiol
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
J Am Soc Echocardiogr
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
J Am Soc Echocardiogr
A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion
J Am Coll Cardiol
Left ventricular function after valve repair for chronic mitral regurgitation: Predictive value of preoperative assessment of contractile reserve by exercise echocardiography
J Am Coll Cardiol
Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation
J Thorac Cardiovasc Surg
Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications
J Am Coll Cardiol
Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications
J Am Soc Echocardiogr
Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress
J Am Coll Cardiol
Cited by (0)
The present study was funded in its entirety by the Mount Sinai School of Medicine (New York, NY). Dr Sengupta has received research grants and support from TomTec Imaging Systems (Munich, Germany) and Forest Laboratories (New York, NY) and is an advisor to Medical Intelligence (Las Vegas, NV), and Saffron Technologies (Cary, NC). He is an inventor with Royalty Agreement with Mayo Medical Ventures for “Method for Imaging Intracavitary Blood Flow Patterns.”
Dr. Adams is an inventor with Royalty Agreements with Edwards Lifesciences and Medtronic for the Physio II Mitral Annuloplasty Ring, IMR ETlogix Mitral Annuloplasty Ring, and TriAd Tricuspid Annuloplasty Ring. National CO-PI: Core Valve-Medtronic US Pivotal Trial.
Drs Pandis and Sengupta contributed equally to the preparation of this report.